Recruiting
Phase 4

Phenylephrine vs. Norepinephrine

Sponsor:

Mayo Clinic

Code:

NCT07796282

Conditions

Spine Surgery

Intraoperative Hypotension

Tissue Perfusion

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Phenylephrine hydrochloride infusion

Norepinephrine bitartrate infusion

Study Details

Brief summary:

The purpose of this research is to compare two commonly used medications, phenylephrine and norepinephrine, that are used to treat low blood pressure during complex spine surgery. The goal is to determine whether one medication better maintains blood flow to the body's organs during surgery and whether it leads to better recovery and fewer complications after surgery.

Conditions

Spine Surgery

Intraoperative Hypotension

Tissue Perfusion

Study ID

NCT07796282

Start date

Sep 30, 2026

Status verified date

Nov, 2026

Completion date

May, 2028

Anticipated

Primary completion date

May, 2028

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Scheduled for elective complex spine surgery including posterior fusion of 5 or more levels of the thoracic and/or lumbar region.
  • ASA physical status classification I-III.
  • Able to provide informed consent.

Exclusion Criteria:

  • Known allergies or contraindication to NE or PE.
  • Pregnant or breastfeeding women.
  • Emergency surgeries.
  • Persistent atrial fibrillation
  • LVEF < 40%
  • Moderate or severe valvular dysfunction
  • RVSP ≥ 60 mm Hg
  • Liver failure or cirrhosis
  • eGFR < 15 and/or on hemodialysis
  • Minimally invasive or endoscopic surgeries

Study Design

Enrollment

50 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Treatment

Interventions and Outcome Measures

Arms

active comparator: Phenylephrine

Participants assigned to this group will undergo elective complex spine surgery with intraoperative blood pressure support managed using phenylephrine as the assigned first-line vasopressor strategy.

experimental: Norepinephrine

Participants assigned to this group will undergo elective complex spine surgery with intraoperative blood pressure support managed using norepinephrine as the assigned first-line vasopressor strategy.

Interventions

Phenylephrine hydrochloride infusion

Phenylephrine hydrochloride will be prepared at a concentration of 40 mcg/mL and initiated at 0.2 mcg/kg/min. The infusion will be titrated intraoperatively to maintain MAP greater than 85 mmHg from surgical manipulation of vertebrae until final wound closure.

Norepinephrine bitartrate infusion

Norepinephrine bitartrate will be prepared at a concentration of 16 mcg/mL, equivalent to 8.47 mcg/mL norepinephrine base, and initiated at 0.02 mcg/kg/min. The infusion will be titrated intraoperatively to maintain MAP greater than 85 mmHg from surgical manipulation of vertebrae until final wound closure.

Primary outcome measure

  • Peak Intraoperative Serum Lactate [ Time Frame: Intraoperatively, from initiation of lactate monitoring through final wound closure ]

Central Contacts and Locations

Central contacts

Locations

Mayo Clinic

Recruiting

Jacksonville, Florida, United States, 32224

Contacts

More Information

Sponsor

Mayo Clinic

Last update posted

Nov 20, 2026

Last verified

Nov, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-21. This information was provided to ClinicalTrials.gov by Mayo Clinic on 2026-11-20. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.